BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

Biomaterials-assisted spheroid engineering for regenerative therapy
Na-Hyun Lee 1 (Graduate student), Oyunchimeg Bayaraa 1 (Graduate student), Zhou Zechu 1 (Graduate student), Hye Sung Kim 1,* (Professor)
1Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 31116, Republic of Korea,
2Department of Nanobiomedical Science and BK21 NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan, 31116, Republic of Korea,
3Department of Regenerative Dental Medicine, College of Dentistry, Dankook University, Cheonan 31116, Republic of Korea
Cell-based therapy is a promising approach in the field of regenerative medicine. As cells are formed into spheroids, their survival, functions, and engraftment in the transplanted site are significantly improved compared to single cell transplantation. To improve the therapeutic effect of cell spheroids even further, various biomaterials (e.g., nano- or microparticles, fibers, and hydrogels) have been developed for spheroid engineering. These biomaterials not only can control the overall spheroid formation (e.g., size, shape, aggregation speed, and degree of compaction), but also can regulate cell-to-cell and cell-to-matrix interactions in spheroids. Therefore, cell spheroids in synergy with biomaterials have recently emerged for cell-based regenerative therapy. Biomaterials-assisted spheroid engineering has been extensively studied for regeneration of bone or/and cartilage defects, critical limb ischemia, and myocardial infarction. Furthermore, it has been expanded to pancreas islets and hair follicle transplantation. This paper comprehensively reviews biomaterials-assisted spheroid engineering for regenerative therapy.
Abstract, Accepted Manuscript(in press) [Submitted on May 6, 2021, Accepted on June 15, 2021]
  Copyright © KSBMB. All rights reserved. / Powered by INFOrang Co., Ltd